Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
1234567
8
9
10
11
121314
15161718192021
222324
25
262728
2930     
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence

Catasys Health - Wednesday, November 25, 2009

Harold Urschel, Research Across America, Dallas, Texas
Published in the Journal of Psychopharmacology, November 25, 2009
 » More


Health Plans: $160 Million Problem

Catasys Health - Wednesday, November 11, 2009
For every 1 million members in a health plan, approximately $160 million in claims are incurred by members diagnosed with Substance Dependence. Most health plans have realistic cost savings opportunities in the millions of dollars. Our Medical Economics group can demonstrate specific savings opportunities for health plans with respect to both medical and behavioral costs. 

The OnTrak program addresses many of the challenges experts highlight within the existing treatment paradigm for substance dependence. Specifically, OnTrak:
 » More

Focused for Impact: Targeting Your Most Difficult SD Members

Catasys Health - Monday, November 09, 2009

We target a health plan’s most difficult substance dependent members, the High-Utilizers, many of whom have relapsed several times. These members indicate that current treatment methods don’t work for them. Unlike other programs, the medical component of the OnTrak treatment program is actually most effective with these individuals who have relapsed multiple times. The psychosocial component and year-long support also contribute to sobriety and reduced hospital stays. » More
| 1 |

 
 
  Tags
 
placebo OxyContin cigarettes dependence issues drug abuse physician- patient relations primary care pain killers meth facebook social network opiod-based treatment behavioral health Journal of Psychopharmacology medical and behavioral costs behavioral healthcare services double-blind opioid antagonist medical opioid overdose methadone pain medication health reform hospitalizations stress narcotic drug addiction ADHD withdrawal drinking muscle relaxant high-utilizing substance dependence health insurance health plan reducing craving codeine Catasys reduction in craving randomized recovery depression screening behavioral healthcare trauma oxycodone overdose binge drinking UnitedHealthcare alcoholism suboxone nicotine drug overdose buprenorphine smoking sober ER chronic pain addiction OnTrak Raymond Anton PTSD vivitrol care coaching drug addicts alcohol dependence addiction treatment relapse prevention substance dependence morphine cocaine treatment gabapentin flumazenil opioid opioid-drug interactions mental illness hydrocodone substance dependence costs methamphetamine Opioid Prescribing relapse painkillers urine drug screen vicodin psychosocial contract alcohol sobriety post-traumatic stress disorder medical costs alcohol drinking substance use disorder behavioral health care services stratified emergency room craving score methamphetamine dependence opiates predictive modeling bipolar disorder CIWA placebo-controlled SD health insurance health insurance alcohol treatment sugar opioid abuse communication addict diabetes cocaine ADD naloxone SD members behavioral health care prescriptions Co Occurring Disorders craving recovery network data mining depression opiod abuse percocet pain pills heroin stimulants hospital Opioid Treatment Research Across America mental health drug treatment Opioid Medications over-the-counter substances Health Care Utilization Harold Urschel drug use identification reduction in use prometa marijuana anxiety fentanyl
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy/Photo Disclaimer
 
  Copyright © 2013 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025 | Toll Free: 1-866-517-1414